167 related articles for article (PubMed ID: 34590588)
1. Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review.
Valenza C; Porta FM; Rappa A; Guerini-Rocco E; Viale G; Barberis M; de Marinis F; Curigliano G; Catania C
Curr Oncol; 2021 Aug; 28(5):3384-3392. PubMed ID: 34590588
[TBL] [Abstract][Full Text] [Related]
2. [Breast metastases from lung cancers with the EGFR mutation].
Assouline P; Léger-Ravet MB; Saffroy R; Hamelin J; Bénissad A; Husleag P; Lemoine A; Oliviéro G
Rev Mal Respir; 2017 Jan; 34(1):61-65. PubMed ID: 27282326
[TBL] [Abstract][Full Text] [Related]
3. EGFR Mutated Lung Adenocarcinoma Metastasis to the Pancreas Mimicking Primary Pancreatic Ductal Carcinoma.
Cao C; Kong MX; Kapali M; Moezardalan K; Shi Q; Azarm A; Lai J
Anticancer Res; 2020 Aug; 40(8):4401-4404. PubMed ID: 32727769
[TBL] [Abstract][Full Text] [Related]
4. Comparison of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lung adenocarcinoma harboring different epidermal growth factor receptor mutation types.
Park S; Lee SY; Kim D; Sim YS; Ryu JS; Choi J; Lee SH; Ryu YJ; Lee JH; Chang JH
BMC Cancer; 2021 Jan; 21(1):52. PubMed ID: 33430803
[TBL] [Abstract][Full Text] [Related]
5. A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages.
Watanabe H; Ohashi K; Nishii K; Seike K; Makimoto G; Hotta K; Maeda Y; Kiura K
Intern Med; 2019 Oct; 58(20):3033-3037. PubMed ID: 31292383
[TBL] [Abstract][Full Text] [Related]
6. Early Application of Next-Generation Sequencing Identifies Pancreatic Mass as Metastasis From an EGFR-Mutated Lung Adenocarcinoma.
Chen L; Davelaar J; Gaddam S; Kosari K; Nissen N; Chaux G; Lee C; Vail E; Hendifar A; Gong J; Reckamp K; Osipov A
J Natl Compr Canc Netw; 2022 Nov; 21(1):6-11. PubMed ID: 36395704
[TBL] [Abstract][Full Text] [Related]
7. Quantitative targeted proteomic analysis of potential markers of tyrosine kinase inhibitor (TKI) sensitivity in EGFR mutated lung adenocarcinoma.
Awasthi S; Maity T; Oyler BL; Qi Y; Zhang X; Goodlett DR; Guha U
J Proteomics; 2018 Oct; 189():48-59. PubMed ID: 29660496
[TBL] [Abstract][Full Text] [Related]
8. Epidermal Growth Factor Receptor Mutation Detection in Cerebrospinal Fluid of Lung Adenocarcinoma Patients with Leptomeningeal Metastasis.
Huang R; Ge M; Zhou X; Ji X; Liao L; Liang X; Zhan Q
Cancer Biother Radiopharm; 2019 Mar; 34(2):128-133. PubMed ID: 30452286
[TBL] [Abstract][Full Text] [Related]
9. The prognostic effect of the epidermal growth factor receptor gene mutation on recurrence dynamics of lung adenocarcinoma.
Park IK; Hyun K; Kim ER; Park S; Kang CH; Kim YT
Eur J Cardiothorac Surg; 2018 Dec; 54(6):1022-1027. PubMed ID: 29878144
[TBL] [Abstract][Full Text] [Related]
10. Concomitant EGFR Mutation and EML4-ALK Rearrangement in Lung Adenocarcinoma Is More Frequent in Multifocal Lesions.
Fan J; Dai X; Wang Z; Huang B; Shi H; Luo D; Zhang J; Cai W; Nie X; Hirsch FR
Clin Lung Cancer; 2019 Jul; 20(4):e517-e530. PubMed ID: 31138506
[TBL] [Abstract][Full Text] [Related]
11. Case report: small cell transformation and metastasis to the breast in a patient with lung adenocarcinoma following maintenance treatment with epidermal growth factor receptor tyrosine kinase inhibitors.
Lin Q; Cai GP; Yang KY; Yang L; Chen CS; Li YP
BMC Cancer; 2016 Aug; 16():593. PubMed ID: 27488410
[TBL] [Abstract][Full Text] [Related]
12. [Plasma relative abundance of epidermal growth factor receptor mutations predicts clinical response to epidermal growth factor receptor-tyrosine kinase inhibitors in patients with advanced lung adenocarcinoma].
Xu HY; Lai QQ; Su SS; Zhou LP; Ye JR; Zhang DQ; Xie YP; Li YP
Zhonghua Nei Ke Za Zhi; 2019 Jan; 58(1):49-55. PubMed ID: 30605951
[No Abstract] [Full Text] [Related]
13. Primary resistance to icotinib in a patient with lung adenocarcinoma harboring EGFR L858R and Q787k mutations.
Heng W; You C; Shangli C; Chuang Q; Mingzhe X
Lung Cancer; 2019 Oct; 136():153-155. PubMed ID: 31422893
[No Abstract] [Full Text] [Related]
14. Prognostic factors of EGFR-mutated metastatic adenocarcinoma of lung.
Ng KS; King Sun C; Boom Ting K; Ting Kun AY
Eur J Radiol; 2020 Feb; 123():108780. PubMed ID: 31846863
[TBL] [Abstract][Full Text] [Related]
15. Identification of epidermal growth factor receptor mutations in pulmonary adenocarcinoma using dual-energy spectral computed tomography.
Li M; Zhang L; Tang W; Jin YJ; Qi LL; Wu N
Eur Radiol; 2019 Jun; 29(6):2989-2997. PubMed ID: 30367185
[TBL] [Abstract][Full Text] [Related]
16. Radical Resection for Second EGFR-mutated Primary Lung Cancer Following Immune Checkpoint Inhibitor Monotherapy for Stage IV Lung Adenocarcinoma.
Horibe R; Hatakeyama T; Ishikawa T; Sawai T; Hashimoto M; Domen H; Takakuwa Y; Satoh M; Nishiyama K
Intern Med; 2022 Feb; 61(3):401-405. PubMed ID: 34393158
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: a case report.
Jin B; Zhang S; Chuang X; Yu P; Chen Y; Teng Y; Che X; Fan Y; Zheng C; Li X; Qiu X; Qu X; Liu Y
BMC Cancer; 2018 Nov; 18(1):1138. PubMed ID: 30453894
[TBL] [Abstract][Full Text] [Related]
18. Comparing the effects of afatinib with gefitinib or Erlotinib in patients with advanced-stage lung adenocarcinoma harboring non-classical epidermal growth factor receptor mutations.
Shen YC; Tseng GC; Tu CY; Chen WC; Liao WC; Chen WC; Li CH; Chen HJ; Hsia TC
Lung Cancer; 2017 Aug; 110():56-62. PubMed ID: 28676220
[TBL] [Abstract][Full Text] [Related]
19. An EGFR-mutated Lung Adenocarcinoma Undergoing Squamous Cell Carcinoma Transformation Exhibited a Durable Response to Afatinib.
Sato M; Matsui A; Shimoyama Y; Omote N; Morise M; Hase T; Tanaka I; Suzuki K; Hasegawa Y
Intern Med; 2018 Dec; 57(23):3429-3432. PubMed ID: 30101911
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary pleomorphic carcinoma: A case harboring EGFR mutation treated with EGFR-TKIs.
Masuda K; Tokito T; Azuma K; Yanagida E; Nakamura M; Naito Y; Matsuo N; Ishii H; Yamada K; Akiba J; Hoshino T
Thorac Cancer; 2018 Jun; 9(6):754-757. PubMed ID: 29675860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
